Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Methotrexate. Found 9 abstracts

Cohen EE, Soulieres D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet (London, England). 2019 Jan 12;393(10167):156-67.
Galsky MD, Pal SK, Chowdhury S, Harshman LC, Crabb SJ, Wong YN, Yu EY, Powles T, Moshier EL, Ladoire S, Hussain SA, Agarwal N, Vaishampayan UN, Recine F, Berthold D, Necchi A, Theodore C, Milowsky MI, Bellmunt J, Rosenberg JE, Retrospective International Study of Cancers of the Urothelial Tract I. Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer. Cancer. 2015 Aug;121(15):2586-93.
Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity. J Clin Oncol. 2014 Jun 20;32(18):1895-901.   PMCID: PMC4050203
Chen ZS, Lee K, Walther S, Raftogianis RB, Kuwano M, Zeng H, Kruh GD. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res. 2002 Jun;62(11):3144-50.
Cianfrocca M, Goldstein LJ. Operable breast cancer. Current treatment options in oncology. 2001 Apr;2(2):157-67.
Zeng H, Chen ZS, Belinsky MG, Rea PA, Kruh GD. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res. 2001 Oct;61(19):7225-32.
Held-Warmkessel J. Methotrexate. Clinical journal of oncology nursing. 2000 Jul;4(4):187-8.
Lee K, Klein-Szanto AJ, Kruh GD. Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. Journal of the National Cancer Institute. 2000 Dec 06;92(23):1934-40.
Zeng H, Liu G, Rea PA, Kruh GD. Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res. 2000 Sep;60(17):4779-84.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Methotrexate

Methotrexate metabolism therapeutic use Human analogs & derivatives Antineoplastic Combined Chemotherapy Protocols US Gov't Support-PHS administration & dosage Female Male drug therapy Non-US Gov't Support Middle Aged Carrier Proteins pharmacokinetics Aged Antineoplastic Antimetabolites pathology Cisplatin Animal Neoadjuvant Therapy Doxorubicin 3T3 Cells genetics pharmacology ATP-Binding Cassette Transporters 80 and over Aged Transitional Cell Carcinoma Polyglutamic Acid Tritium Osmosis Cell Line administration & US Gov't Support-Non-PHS Treatment Outcome mortality drug effects Anion Transport Proteins Kaplan-Meier Estimate Mice methods Transfection Folic Acid Disease-Free Survival secondary Vinblastine Drug Administration Schedule Urinary Bladder Neoplasms Multiple Drug Resistance Neoplasm Invasiveness Adult Multidrug Resistance-Associated Proteins dosage adverse effects Practice Guidelines Bone Marrow effects Retrospective Studies virology Patient Selection Tamoxifen Recombinant Proteins Fluorouracil Neoplasm Drug Resistance Phytogenic Antineoplastic Agents Patient Education neoadjuvant Antineoplastic Agents Premedication Liposomes Squamous Cell Carcinoma of Head and Neck P-Glycoproteins muscle invasion radiotherapy Molecular Cloning Complementary DNA Adjuvant Chemotherapy chemically induced physiology Oncologic Nursing nursing Fatigue Cetuximab Survival Analysis Leukotriene C4 vinblastine Insects Monoclonal Antibodies-Humanized Gene Expression Profiling Disease Progression surgery Leucovorin Breast Neoplasms Local Neoplasm Recurrence Immunoblotting chemistry methotrexate Cell Membrane Osmolar Concentration Hormone-Dependent Neoplasms Active Biological Transport cisplatin Filgrastim Kidney Glutathione Neoplasm Staging Glycocholic Acid Deoxycytidine antagonists & inhibitors P-Glycoprotein Granulocyte Colony-Stimulating Factor Multicenter Studies as Topic Antitumor Drug Screening Assays Immunohistochemistry Kinetics Protective Agents Drug Monitoring Tumor Biomarkers bladder cancer Substrate Specificity Metabolic Clearance Rate Baculoviridae Drug Interactions Docetaxel Adenosine Triphosphate Swine Acrylates Muscle Neoplasms plus cisplatin Carbon Radioisotopes gemcitabine plus cisplatin LLC-PK1 Cells Polyethylene Glycols Prospective Studies Anthracycline Antibiotics Prostate cytology Estradiol analysis Combined Modality Therapy adverse doxorubicin Head and Neck Neoplasms Comparative Study Biological Transport Polymers statistics & numerical data
Last updated on Monday, July 06, 2020